These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 32725629)

  • 1. Long-term survival in triple-vessel disease: Hybrid coronary revascularization compared to contemporary revascularization methods.
    Basman C; Hemli JM; Kim MC; Seetharam K; Brinster DR; Pirelli L; Kliger CA; Scheinerman SJ; Singh VP; Patel NC
    J Card Surg; 2020 Oct; 35(10):2710-2718. PubMed ID: 32725629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution.
    Shen L; Hu S; Wang H; Xiong H; Zheng Z; Li L; Xu B; Yan H; Gao R
    J Am Coll Cardiol; 2013 Jun; 61(25):2525-33. PubMed ID: 23623906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.
    Puskas JD; Halkos ME; DeRose JJ; Bagiella E; Miller MA; Overbey J; Bonatti J; Srinivas VS; Vesely M; Sutter F; Lynch J; Kirkwood K; Shapiro TA; Boudoulas KD; Crestanello J; Gehrig T; Smith P; Ragosta M; Hoff SJ; Zhao D; Gelijns AC; Szeto WY; Weisz G; Argenziano M; Vassiliades T; Liberman H; Matthai W; Ascheim DD
    J Am Coll Cardiol; 2016 Jul; 68(4):356-65. PubMed ID: 27443431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients≥65 years with multivessel coronary artery disease.
    Harskamp RE; Puskas JD; Tijssen JG; Walker PF; Liberman HA; Lopes RD; Vassiliades TA; Peterson ED; Halkos ME
    Am J Cardiol; 2014 Jul; 114(2):224-9. PubMed ID: 24878119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid total arterial minimally invasive off-pump coronary revascularization and percutaneous coronary intervention strategy for multivessel coronary artery disease: a cohort study with a median 11-year follow-up.
    Rufa M; Ursulescu A; Nagib R; Albert M; Franke UFW
    Cardiovasc Diagn Ther; 2024 Apr; 14(2):272-282. PubMed ID: 38716312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid revascularization for multivessel coronary artery disease.
    Gąsior M; Zembala MO; Tajstra M; Filipiak K; Gierlotka M; Hrapkowicz T; Hawranek M; Poloński L; Zembala M;
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1277-83. PubMed ID: 25459040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid coronary revascularization versus coronary artery bypass surgery with bilateral or single internal mammary artery grafts.
    Rosenblum JM; Harskamp RE; Hoedemaker N; Walker P; Liberman HA; de Winter RJ; Vassiliades TA; Puskas JD; Halkos ME
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):1081-9. PubMed ID: 26687889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and Clinical Outcomes at One Year-Hybrid coronary REvascularization Versus Stenting or Surgery (HREVS).
    Ganyukov V; Kochergin N; Shilov A; Tarasov R; Skupien J; Szot W; Kokov A; Popov V; Kozyrin K; Barbarash O; Barbarash L; Musialek P
    J Interv Cardiol; 2020; 2020():5458064. PubMed ID: 31969796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus.
    Harskamp RE; Walker PF; Alexander JH; Xian Y; Liberman HA; de Winter RJ; Vassiliades TA; Peterson ED; Puskas JD; Halkos ME
    Am Heart J; 2014 Oct; 168(4):471-8. PubMed ID: 25262256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Effectiveness of Hybrid Coronary Revascularization vs Coronary Artery Bypass Grafting.
    Harskamp RE; Vassiliades TA; Mehta RH; de Winter RJ; Lopes RD; Xian Y; Peterson ED; Puskas JD; Halkos ME
    J Am Coll Surg; 2015 Aug; 221(2):326-34.e1. PubMed ID: 25899734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid Coronary Revascularization: Early Outcomes and Midterm Follow-Up in Patients Undergoing Single or Multivessel Robotic TECAB and PCI.
    Nisivaco SM; Kitahara H; Abutaleb AR; Nathan S; Balkhy HH
    Innovations (Phila); 2022; 17(6):513-520. PubMed ID: 36529976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid Coronary Artery Revascularization: A Review and Current Evidence.
    Kiaii B; Teefy P
    Innovations (Phila); 2019 Oct; 14(5):394-404. PubMed ID: 31500492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting: Comparative Effectiveness Analysis With Long-Term Follow-up.
    Hage A; Giambruno V; Jones P; Chu MW; Fox S; Teefy P; Lavi S; Bainbridge D; Harle C; Iglesias I; Dobkowski W; Kiaii B
    J Am Heart Assoc; 2019 Dec; 8(24):e014204. PubMed ID: 31826727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Clinical Trial of Hybrid vs. Surgical vs. Percutaneous Multivessel Coronary Revascularization: 5‑year Follow-up of HREVS Trial.
    Ganyukov VI; Kochergin NA; Shilov AA; Tarasov RS; Kozyrin KA; Prokudina ES; Barbarash OL; Barbarash LS
    Kardiologiia; 2023 Dec; 63(11):57-63. PubMed ID: 38088113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and angiographic results after hybrid coronary revascularization.
    Halkos ME; Walker PF; Vassiliades TA; Douglas JS; Devireddy C; Guyton RA; Finn AV; Rab ST; Puskas JD; Liberman HA
    Ann Thorac Surg; 2014 Feb; 97(2):484-90. PubMed ID: 24140212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid Coronary Revascularization Versus On-Pump Coronary Artery Bypass Grafting.
    Giambruno V; Jones P; Khaliel F; Chu MW; Teefy P; Sridhar K; Cucchietti C; Barnfield R; Kiaii B
    Ann Thorac Surg; 2018 May; 105(5):1330-1335. PubMed ID: 29571730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary Outcomes Following Coronary Artery Bypass Graft Surgery for Left Main Disease.
    Modolo R; Chichareon P; Kogame N; Dressler O; Crowley A; Ben-Yehuda O; Puskas J; Banning A; Taggart DP; Kappetein AP; Sabik JA; Onuma Y; Stone GW; Serruys PW
    J Am Coll Cardiol; 2019 Apr; 73(15):1877-1886. PubMed ID: 30999989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry.
    Lowenstern A; Wu J; Bradley SM; Fanaroff AC; Tcheng JE; Wang TY
    Am Heart J; 2019 Sep; 215():167-177. PubMed ID: 31349108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.